Stock Chart
GLUE
Type: SELL wallstreet
Strike: $18
Premium: $1.95
Expiry: Apr 17, 2026
Target: $17
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About GLUE - Monte Rosa Therapeutics, Inc. Common Stock
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in …
Key Statistics
More GLUE Analysis
This GLUE stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track GLUE's price movements with trendlines, gamma walls, and key support/resistance levels.